Search Results - Yoko Hamada
- Showing 1 - 5 results of 5
-
1
-
2
Chemoattractants for neutrophils in lipopolysaccharide‐induced inflammatory exudate from rats are not interleukin‐8 counterparts but gro‐gene‐product/melanoma‐growth‐stimulating‐ac... by Kazuyoshi Watanabe, Megumi Iida, Kiyosumi Takaishi, Tadaaki SUZUKI, Yoko Hamada, Yoshio Iizuka, Susumu Tsurufuji
Published 1993Artigo -
3
HDL/Apolipoprotein A-I Binds to Macrophage-Derived Progranulin and Suppresses its Conversion into Proinflammatory Granulins by Hanayuki Okura, Shizuya Yamashita, Tohru Ohama, Ayami Saga, Aya Yamamoto-Kakuta, Yoko Hamada, Nagako Sougawa, Reiko Ohyama, Yoshiki Sawa, Akifumi Matsuyama
Published 2010Artigo -
4
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations by Takayuki Yoshino, Yoshito Komatsu, Yasuhide Yamada, Kentaro Yamazaki, Akihito Tsuji, Takashi Ura, Axel Grothey, Eric Van Cutsem, Thierry André, Frank Cihon, Yoko Hamada, Atsushi Ohtsu
Published 2014Artigo -
5
Large-Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real-World Clinical Setting by Kensei Yamaguchi, Yoshito Komatsu, Taroh Satoh, Hiroyuki Uetake, Takayuki Yoshino, Toshirou Nishida, Naoya Yamazaki, Hajime Takikawa, Takashi Morimoto, Masayuki Chosa, Toshiyuki Sunaya, Yoko Hamada, Kei Muro, Kenichi Sugihara
Published 2019Artigo
Search Tools:
Related Subjects
Medicine
Chemistry
Internal medicine
Adverse effect
Biochemistry
Biology
Cancer
Colorectal cancer
Molecular biology
Receptor
Regorafenib
Alternative medicine
Apolipoprotein B
Aqueous solution
Beta-Cyclodextrins
Botany
Cell biology
Cell culture
Chemotaxis
Cholesterol
Clinical endpoint
Clinical trial
Confidence interval
Cyclodextrin
Cytokine
Dissolution
Drug
Endocrinology
Enzyme
Exudate